Examines how regional vaccine manufacturing can strengthen equitable access to vaccines by shifting decision-making power and building sustainable production capacity. It considers issues including technology transfer, financing, workforce and technical capacity, governance, intellectual property, procurement and partnerships needed to make regional vaccine production sustainable and equitable.